Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology. Takeda will pay ...

Privately-held BridGene Biosciences has announced a strategic collaboration and licensing agreement with Japan’s Takeda. The ...

The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of novel therapeutics,” said Jasbir S. Seehra, Ph.D., Chair and Chief Executive ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive ...

In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

Trump's trade threats and tariffs target various countries and industries, sparking fears of a global trade war.

Trimester, the University launches new degree and certificate programs in the areas of healthcare, legal, operations and ...

Polycythemia Vera is a rare disorder marked by a continuous rise in the number of red blood cells in the blood, with an ...

This year's Fujisankei Ladies Classic golf tournament, scheduled for April 25-27 in Shizuoka Prefecture, will be canceled, Japan LPGA Tour sources said Wednesday. Main tournament sponsor Fuji ...

Rajiv Onat, India head, digital technology and engineering, Regeneron, acknowledged Telangana’s role in creating a ...

Bryan Supran, non-executive director and representative of Pfizer, stepped down from the Haleon board of directors. Elizabeth Holmes, the disgraced founder of Theranos, will remain in prison after ...

The new regional registry for rare disease patients in Campania, inaugurated in January, the multidisciplinary ...